VitaNova Life Sciences (VNOV) Net Cash Flow (2017 - 2026)
VitaNova Life Sciences (VNOV) reported Net Cash Flow of -$90377.0 for Q1 2026, down 149.55% on a YoY basis from $182378.0 in Q1 2025, and down 142.5% quarter-over-quarter from $212661.0 in Q4 2025.
VitaNova Life Sciences (VNOV) Net Cash Flow (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported Net Cash Flow for 9 years, with the latest figure at -$90377.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 149.55% year-over-year to -$90377.0; the trailing twelve-month figure through Jan 2026 stood at $763731.0 (up 289.43% YoY), and the FY2025 full-year result was $189774.0, down 67.52% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$90377.0, down from $212661.0 in the prior quarter.
- The five-year high for Net Cash Flow was $808356.0 in Q1 2024, with the low at -$451401.0 in Q3 2024.
- Historically, Net Cash Flow has averaged $71075.7 across 5 years, with a median of $5274.0 in 2022.
- The largest YoY upside for Net Cash Flow was 3443.49% in 2024 against a maximum downside of 9323.19% in 2024.
- VitaNova Life Sciences' Net Cash Flow stood at $5306.0 in 2022, then tumbled by 264.49% to -$8728.0 in 2023, then jumped by 1029.88% to $81160.0 in 2024, then jumped by 162.03% to $212661.0 in 2025, then sank by 142.5% to -$90377.0 in 2026.
- The last three Net Cash Flow figures came in at -$90377.0 (Q1 2026), $212661.0 (Q4 2025), and $263810.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.03 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 442.31 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 1.16 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -40.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 54.93 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -5.10 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 4.86 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -1.43 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -90,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -90,377.00 |
| Jan 31, 2026 | -90,377.00 |
| Oct 31, 2025 | 212,661.00 |
| Oct 31, 2025 | 212,661.00 |
| Jul 31, 2025 | 263,810.00 |
| Jul 31, 2025 | 263,810.00 |
| Apr 30, 2025 | 377,637.00 |
| Apr 30, 2025 | 377,637.00 |
| Jan 31, 2025 | 182,378.00 |
| Jan 31, 2025 | 182,378.00 |
| Oct 31, 2024 | 81,160.00 |
| Oct 31, 2024 | 81,160.00 |
| Jul 31, 2024 | -451,401.00 |
| Jul 31, 2024 | -451,401.00 |
| Apr 30, 2024 | -215,320.00 |
| Apr 30, 2024 | -215,320.00 |
| Jan 31, 2024 | 808,356.00 |
| Jan 31, 2024 | 808,356.00 |
| Jul 31, 2023 | -8,728.00 |
| Jul 31, 2023 | -8,728.00 |